Why is GKB Ophthalmics falling/rising?

As of 19-Sep, GKB Ophthalmics Ltd is experiencing a decline in its stock price, currently at Rs 70.00, reflecting a decrease of Rs 2.7 or 3.71%. The stock has underperformed its sector by 3.12% today, reaching an intraday low of Rs 70. The trading activity indicates that more volume was traded close to this low price, and the stock is currently below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Additionally, there has been a significant drop in investor participation, with delivery volume falling by 71.13% compared to the 5-day average. The company's long-term fundamentals are weak, highlighted by a -166.65% CAGR growth in operating profits over the last five years and a negative EBIT to interest ratio of -0.20, indicating challenges in servicing its debt.
In the broader market context, GKB Ophthalmics has consistently underperformed against the benchmark, with a 1-week return of -2.99% compared to the Sensex's +0.88%. Over the past year, the stock has generated a return of -36.91%, while the Sensex has remained relatively flat with a -0.67% return. This consistent underperformance, coupled with negative EBITDA and declining cash reserves, suggests a challenging environment for the company, further contributing to the downward pressure on its stock price.